Shares of 23andMe sank Thursday, a day after the company reported dismal third-quarter fiscal 2024 results and discussed splitting itself in two to help juice its stock price. 23andMe reported revenue ...

SUNNYVALE, Calif. and LONDON, Jan. 08, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (ME), a leading human genetics company, today announced the launch of Discover23®, a new research offering enabling ...

Regeneron Pharmaceuticals announced on Monday that it will acquire "substantially all" of genetic testing company 23andMe's assets. The pharmaceutical company said it won the court-supervised auction ...

23andMe has filed for Chapter 11 bankruptcy protection and its co-founder and CEO has resigned as the struggling genetic testing company continues its push to cut costs. Bay Area-based 23andMe ...

23andMe offers reports, among which are those based on statistical models known as polygenic scores (PRS). The PRS reports are developed by 23andMe scientists and clinical experts using the company’s ...

23andMe has filed for Chapter 11 bankruptcy protection and its co-founder and CEO has resigned as the struggling genetic testing company continues its push to cut costs. San Francisco-based 23andMe ...

Figuring out precisely where you come from and who your ancestors are has grown in popularity with the uptick in easy-to-use, over-the-counter genetic testing kits. And now, with the added ability to ...

Genetics testing company 23andMe on Monday announced a deal to be acquired by biotechnology company Regeneron. The $256 million sale is subject to court oversight, and still needs approval. The sale ...

NEW YORK (AP) — 23andMe has filed for Chapter 11 bankruptcy protection and its co-founder and CEO has resigned as the struggling genetic testing company continues its push to cut costs. San ...

Genetic testing company 23andMe filed for Chapter 11 bankruptcy protection to help the $50 million company sell itself, the company announced Sunday. 23andMe's saliva-based kits have been helping ...

23andMe is helping collaborators better understand disease biology, identify novel targets, boost clinical trial success, and engage people in their care SUNNYVALE, Calif. and LONDON, Jan. 08, 2025 ...

23andMe has filed for Chapter 11 bankruptcy protection and its co-founder and CEO has resigned as the struggling genetic testing company continues its push to cut costs. The Sunnyvale, Calif.-based ...